Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 3
2005 7
2006 10
2007 14
2008 10
2009 21
2010 24
2011 20
2012 25
2013 35
2014 38
2015 45
2016 49
2017 45
2018 34
2019 57
2020 74
2021 86
2022 79
2023 88
2024 34

Text availability

Article attribute

Article type

Publication date

Search Results

711 results

Results by year

Filters applied: . Clear all
Page 1
Aptamer-Based Targeted Protein Degradation.
Liu Y, Qian X, Ran C, Li L, Fu T, Su D, Xie S, Tan W. Liu Y, et al. Among authors: su d. ACS Nano. 2023 Apr 11;17(7):6150-6164. doi: 10.1021/acsnano.2c10379. Epub 2023 Mar 21. ACS Nano. 2023. PMID: 36942868 Review.
The involvement of TH17 cells in the pathogenesis of IBD.
Jiang P, Zheng C, Xiang Y, Malik S, Su D, Xu G, Zhang M. Jiang P, et al. Among authors: su d. Cytokine Growth Factor Rev. 2023 Feb;69:28-42. doi: 10.1016/j.cytogfr.2022.07.005. Epub 2022 Jul 19. Cytokine Growth Factor Rev. 2023. PMID: 35871978 Review.
Multiomics analyses reveal DARS1-AS1/YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistance.
Zheng C, Wei Y, Zhang Q, Sun M, Wang Y, Hou J, Zhang P, Lv X, Su D, Jiang Y, Gumin J, Sahni N, Hu B, Wang W, Chen X, McGrail DJ, Zhang C, Huang S, Xu H, Chen J, Lang FF, Hu J, Chen Y. Zheng C, et al. Among authors: su d. Sci Adv. 2023 Aug 4;9(31):eadf3984. doi: 10.1126/sciadv.adf3984. Epub 2023 Aug 4. Sci Adv. 2023. PMID: 37540752 Free PMC article.
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase.
Guo Y, Liu Y, Hu N, Yu D, Zhou C, Shi G, Zhang B, Wei M, Liu J, Luo L, Tang Z, Song H, Guo Y, Liu X, Su D, Zhang S, Song X, Zhou X, Hong Y, Chen S, Cheng Z, Young S, Wei Q, Wang H, Wang Q, Lv L, Wang F, Xu H, Sun H, Xing H, Li N, Zhang W, Wang Z, Liu G, Sun Z, Zhou D, Li W, Liu L, Wang L, Wang Z. Guo Y, et al. Among authors: su d. J Med Chem. 2019 Sep 12;62(17):7923-7940. doi: 10.1021/acs.jmedchem.9b00687. Epub 2019 Aug 19. J Med Chem. 2019. PMID: 31381333
711 results